Trastuzumab Combined With Chemotherapy or Endocrine Therapy to Treat Metastatic Luminal B2 Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Endocrine therapy combined with trastuzumab|DRUG: Chemotherapy combined with trastuzumab
Sponsor: Sun Yat-sen University